Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pulmonx Corp (LUNG)

Pulmonx Corp (LUNG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 82,906
  • Shares Outstanding, K 41,247
  • Annual Sales, $ 83,790 K
  • Annual Income, $ -56,390 K
  • EBIT $ -57 M
  • EBITDA $ -57 M
  • 60-Month Beta 0.22
  • Price/Sales 1.05
  • Price/Cash Flow N/A
  • Price/Book 1.45

Options Overview Details

View History
  • Implied Volatility 271.83% (+60.19%)
  • Historical Volatility 138.64%
  • IV Percentile 78%
  • IV Rank 39.11%
  • IV High 616.85% on 10/14/25
  • IV Low 50.26% on 03/14/25
  • Expected Move (DTE 11) 0.43 (21.15%)
  • Put/Call Vol Ratio 0.01
  • Today's Volume 770
  • Volume Avg (30-Day) 367
  • Put/Call OI Ratio 0.17
  • Today's Open Interest 10,553
  • Open Int (30-Day) 12,564
  • Expected Range 1.62 to 2.48

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.39
  • Number of Estimates 2
  • High Estimate -0.39
  • Low Estimate -0.39
  • Prior Year -0.33
  • Growth Rate Est. (year over year) -18.18%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.31 +57.25%
on 11/20/25
2.18 -5.72%
on 12/08/25
+0.14 (+7.29%)
since 11/07/25
3-Month
1.31 +57.25%
on 11/20/25
2.89 -28.72%
on 10/28/25
+0.36 (+21.18%)
since 09/08/25
52-Week
1.31 +57.25%
on 11/20/25
9.37 -78.01%
on 02/20/25
-4.34 (-67.81%)
since 12/06/24

Most Recent Stories

More News
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (the “Company” or “Pulmonx”), a global leader in minimally invasive treatments for lung disease, today...

LUNG : 2.04 (+1.49%)
Pulmonx Reports Third Quarter 2025 Financial Results

REDWOOD CITY, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported...

LUNG : 2.04 (+1.49%)
Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025

Glen French, member of the Board of Directors and former Pulmonx President and Chief Executive Officer, reappointed President and Chief Executive Officer Derrick Sung, former Pulmonx Chief Financial Officer,...

LUNG : 2.04 (+1.49%)
Pulmonx to Report Third Quarter 2025 Financial Results on October 29, 2025

REDWOOD CITY, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced...

LUNG : 2.04 (+1.49%)
Pulmonx Reports Second Quarter 2025 Financial Results

REDWOOD CITY, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported...

LUNG : 2.04 (+1.49%)
Pulmonx to Present at the Canaccord Genuity 45th Annual Growth Conference

REDWOOD CITY, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced...

LUNG : 2.04 (+1.49%)
Pulmonx to Report Second Quarter 2025 Financial Results on July 30, 2025

REDWOOD CITY, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced...

LUNG : 2.04 (+1.49%)
Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

LUNG : 2.04 (+1.49%)
Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference

LUNG : 2.04 (+1.49%)
Pulmonx Reports First Quarter 2025 Financial Results

LUNG : 2.04 (+1.49%)

Business Summary

Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California.

See More

Key Turning Points

3rd Resistance Point 2.29
2nd Resistance Point 2.23
1st Resistance Point 2.12
Last Price 2.04
1st Support Level 1.95
2nd Support Level 1.89
3rd Support Level 1.78

See More

52-Week High 9.37
Fibonacci 61.8% 6.29
Fibonacci 50% 5.34
Fibonacci 38.2% 4.39
Last Price 2.04
52-Week Low 1.31

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar